GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Longevity Biomedical Inc (NAS:LBIO) » Definitions » Gross-Profit-to-Asset %

Longevity Biomedical (Longevity Biomedical) Gross-Profit-to-Asset % : 0.00% (As of . 20)


View and export this data going back to 2050. Start your Free Trial

What is Longevity Biomedical Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Longevity Biomedical's annualized Gross Profit for the quarter that ended in . 20 was $ Mil. Longevity Biomedical's average Total Assets over the quarter that ended in . 20 was $ 0 Mil. Therefore, Longevity Biomedical's annualized Gross-Profit-to-Asset % for the quarter that ended in . 20 was Not Available.

Longevity Biomedical Gross-Profit-to-Asset % Historical Data

The historical data trend for Longevity Biomedical's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Longevity Biomedical Gross-Profit-to-Asset % Chart

Longevity Biomedical Annual Data
Trend
Gross-Profit-to-Asset %

Longevity Biomedical Semi-Annual Data
Gross-Profit-to-Asset %

Competitive Comparison of Longevity Biomedical's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Longevity Biomedical's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Longevity Biomedical's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Longevity Biomedical's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Longevity Biomedical's Gross-Profit-to-Asset % falls into.


Longevity Biomedical Gross-Profit-to-Asset % Calculation

Longevity Biomedical's annualized Gross-Profit-to-Asset % for the fiscal year that ended in . 20 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: . 20 )/( (Total Assets (A: . 20 )+Total Assets (A: . 20 ))/ count )
=/( (+)/ )
=/
= %

Longevity Biomedical's annualized Gross-Profit-to-Asset % for the quarter that ended in . 20 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: . 20 )/( (Total Assets (Q: . 20 )+Total Assets (Q: . 20 ))/ count )
=/( (+)/ )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is one times the annual (. 20) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Longevity Biomedical Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Longevity Biomedical's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Longevity Biomedical (Longevity Biomedical) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Longevity Biomedical Inc (NAS:LBIO) » Definitions » Gross-Profit-to-Asset %
Comparable Companies
Traded in Other Exchanges
N/A
Address
12100 NE 195th street, Suite 150, Bothell, WA, USA, 98011
Website
https://www.longevitybiomedical.com
Longevity Biomedical Inc is a clinical-stage biomedical company. The company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span. Longevity is acquiring a differentiated therapeutic pipeline of late-stage clinical technologies across ophthalmology, cardiovascular disease, and soft tissue reconstruction and repair.

Longevity Biomedical (Longevity Biomedical) Headlines

No Headlines